Latest Breaking News On - Locally advanced breast cancer - Page 1 : comparemela.com

Re: Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial

Re: Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

Breast cancer has different metastatic patternsBetter survival thanClinical breast cancerFerreroj mLine trastuzumab plusAromatase inhibitorWithout pertuzumabHuman epidermal growth factor receptorHormone receptorPositive metastaticLocally advanced breast cancerOpen label phaseClinical oncology

What are the clinical considerations of proton radiotherapy for individuals with locally advancing breast cancer?

In a recent review published in Current Oncology, researchers highlighted the technical and clinical considerations for proton radiotherapy delivery for individuals with locally advancing breast malignancies.

Cancer research industryCurrent oncologyProton therapyLocally advanced breast cancerImage creditCancer research industry focusUnited kingdomBreast cancerBreast reconstructionClinical trialProton therapyRadiation therapy